Hydrocortisone base

Hydrocortisone base
Product Description

We have built a new production line of Hydrocortisone (new process) at Hutian Chemical Industrial Zone, which the DUNS and FEI No. of this site have been granted, and this site has been inspected by US FDA in 2016. Our new DMF NO. in US FDA is 33073. And the US FDA will audit us in March of this year and we will get the approved EIR around May. Our capacity of production is 25 mt per year and quality could comply USP and EP. We exported around 7-8 mt to different countries per year. 

Shandong Xinhua Pharmaceutical (USA) Inc.

  • US
  • 2018
    On CPHI since
Specifications
  • CAS Registry Number
    50-23-7
  • Supplied from
    China

Shandong Xinhua Pharmaceutical (USA) Inc.

  • US
  • 2018
    On CPHI since

More Products from Shandong Xinhua Pharmaceutical (USA) Inc. (2)

  • Aspirin ( Acetyl Salicylic Acid)

    Product Aspirin ( Acetyl Salicylic Acid)

    Shandong Xinhua became the biggest producer of Aspirin (also called Acetyl Salicylic Acid)   from the very beginning of 1980s . Now our current capacity is 10,000 tons annually and export 5000 tons quantity for all the worlds. Almost all the countries had registered and used our Aspirin products....
  • IBUPROFEN

    Product IBUPROFEN

    We are biggest manufacturer in the world and have 5000mt per year production capacity.We could comply BP/USP, EP/COS, JP all standard and our exported quantity are 4000mt per year.  Now, we have supplied all big famous company, like Pfizer, Bayer,  Sanofi, GSK, Abbott and Novartis etc. Almos...

Shandong Xinhua Pharmaceutical (USA) Inc. resources (1)

  • Brochure Profile of SHANDONG XINHUA

    Shandong Xinhua is in an leading position in the manufacturing technology and capacity for antipyretics and analgesics in China, also for the drugs of central nervous system, steroids, cardio cerebrovascular system and anti- infection agents. The total capacity of API is more than 35,000mt per year,and  products Analgin, Ibuprofen, Acetylsalicylic Acid, Caffeine and Levodopa are on the top position in the worldwide. Shandong Xinhua is also the key manufacturer for finished dosage formulation in China with the capacity of 10 billion tablets, 1 billion injection units and 200 million capsules per year.